揭露由于被黑客入侵的肝脏系统导致的塔克罗利斯毒性
Priyadarshini Zula1, Belmin B J Winston Gysley2, Ashish Sharma2
1Departments of Pharmacology, and.
Therapeutic drug monitoring
|September 10, 2025
概括
在艾滋病毒-艾滋病的移植患者中,随机与可纳和塔克罗利斯同时服用利托纳维尔导致严重的毒性. 仔细的药物检查对于预防危险的药物相互作用和确保患者安全至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 传染性疾病 传染性疾病
背景情况:
- 已知fluconazole和tacrolimus之间的药物相互作用.
- 添加利托纳维尔显著增强了塔克罗利莫斯的毒性,特别是在患有艾滋病毒和艾滋病的移植患者中.
- 偶然同时服用里托纳维尔需要仔细调整处方.
研究的目的:
- 要突出药物审查在艾滋病毒-艾滋病脏移植接受者的关键重要性.
- 为了强调非故意与可纳和塔克罗利斯同时服用利托纳维尔的严重后果.
- 为治疗药物监测 (TDM) 专家提供有关潜在药物相互作用的信息.
主要方法:
- 一个案例介绍一个52岁的男性脏移植接受者.
- 详细的临床表现,包括塔克罗利斯毒性的症状和实验室发现 (高塔克罗利斯C0,升高的肌素).
- 调查显示,在抗逆转录病毒疗法中,错误地切换到阿塔萨纳维尔加里托纳维尔,同时使用可纳.
主要成果:
- 该患者呈现出严重的塔克罗利斯毒性 (C0 = 139 ng/mL) 和急性损伤 (肌素 = 3.08 mg/dL).
- 鉴定出因是利托纳维尔和可纳对塔克罗利斯新陈代谢的双重抑制.
- 停用塔克罗利斯和支持性护理导致了临床康复,塔克罗利斯在较低剂量下成功重新引入.
结论:
- 这一案例强调了在开处方或分发药物之前,需要进行彻底的药物相互作用审查的必要性.
- 医生和药剂师必须对潜在的相互作用保持警,特别是在多种药物的免疫功能低下患者中.
- 准确的药物调和对于预防危及生命的药物毒性至关重要.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
217
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
217
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Pulmonary Tuberculosis I
846
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
846
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
257
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
257
Hepatic Drug Excretion: Influencing Factors
533
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
533
Toxic Reactions: Overview
1.8K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.8K


